FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Colinz Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:531210 P/E (TTM) :20.16
ISIN Demat:INE923C01011 Div & Yield %:0 EPS (TTM) :3.92
Book Value (RS) :68.416101 Market Cap (Rs Cr.):9.95 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 1.43 1.47 -2.72
Other Income 0.08 0.08 0.00
PBIDT 0.18 0.14 28.57
Interest 0.01 0.01 0.00
PBDT 0.17 0.14 21.43
Depreciation 0.04 0.03 33.33
PBT 0.13 0.11 18.18
Tax 0.04 0.05 -20.00
Deferred Tax 0.00 0.00 0.00
PAT 0.08 0.05 60.00

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)